Key result
Low molecular weight heparin is a safe and effective anticoagulant during pregnancy, offering advantages over unfractionated heparin and warfarin such as a longer half-life, less frequent dosing, and a better safety profile.
Why the study?
Does low molecular weight heparin provide safe and effective anticoagulation in pregnant women compared to unfractionated heparin or warfarin?
Does low molecular weight heparin provide safe and effective anticoagulation in pregnant women compared to unfractionated heparin or warfarin?
LMWH is a safe, effective, and convenient anticoagulant for use during pregnancy, offering significant advantages over unfractionated heparin and warfarin despite its higher cost.
No takes yet. Share an insight, caveat, or question.
May support LMWH consideration in pregnancy; leaves open need for randomized confirmation.
Bangal et al. (2014) conducted a review in Venous thromboembolism and other indications for anticoagulation in pregnancy. Low molecular weight heparin (LMWH) vs. Unfractionated heparin (UFH) or Warfarin was evaluated. Low molecular weight heparin is a safe and effective anticoagulant during pregnancy, offering advantages over unfractionated heparin and warfarin such as a longer half-life, less frequent dosing, and a better safety profile.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: